• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西沙必利用于术后肠梗阻的安慰剂对照试验。

Placebo-controlled trial of cisapride in postoperative ileus.

作者信息

Boghaert A, Haesaert G, Mourisse P, Verlinden M

机构信息

O. L. Vrouw Hospital, Aalst, Belgium.

出版信息

Acta Anaesthesiol Belg. 1987;38(3):195-9.

PMID:3321849
Abstract

The effect of 4 mg of the gastrointestinal motility enhancing agent cisapride on postoperative ileus was compared with that of a placebo in 53 patients who had undergone various types of surgery. They received one i.v. injection of the double-blind medication, or two if no distinct flatus occurred within an hour after the first injection. The placebo response was very limited; borborygmi or flatus did not occur in more than 12% of the patients not even after the second injection. Cisapride was significantly effective: bowel sounds were present in 43% and 50% within 1 hour after the first and second injection of 4 mg, respectively, and flatus in 36% and 43%. The recognition that colon inactivity probably is the major determinant of the ileus, may be indicative of a substantial relative impact of cisapride's stimulating effects on colon motility.

摘要

在53例接受了各类手术的患者中,对比了4毫克胃肠动力增强剂西沙必利与安慰剂对术后肠梗阻的影响。他们接受了一次静脉注射双盲药物,如果在首次注射后一小时内未出现明显的肠胃气胀,则再注射一次。安慰剂的效果非常有限;即使在第二次注射后,超过12%的患者仍未出现肠鸣音或肠胃气胀。西沙必利显著有效:在首次和第二次注射4毫克药物后1小时内,分别有43%和50%的患者出现肠鸣音,36%和43%的患者出现肠胃气胀。认识到结肠不活动可能是肠梗阻的主要决定因素,这可能表明西沙必利对结肠动力的刺激作用具有相当大的相对影响。

相似文献

1
Placebo-controlled trial of cisapride in postoperative ileus.西沙必利用于术后肠梗阻的安慰剂对照试验。
Acta Anaesthesiol Belg. 1987;38(3):195-9.
2
Treatment of postoperative gastrointestinal atony.
Br J Surg. 1987 Jul;74(7):614-7. doi: 10.1002/bjs.1800740727.
3
Effect of cisapride on the post-cholecystectomy upper gastrointestinal transit time.
Int J Clin Pharmacol Ther Toxicol. 1988 May;26(5):265-8.
4
Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial.西沙必利可减轻新生儿术后肠梗阻:随机安慰剂对照试验。
Arch Dis Child Fetal Neonatal Ed. 1997 Sep;77(2):F119-22. doi: 10.1136/fn.77.2.f119.
5
The effect of cholecystokinin on postoperative bowel function.胆囊收缩素对术后肠功能的影响。
Acta Chir Scand. 1985;151(6):557-9.
6
Effect of cisapride on distal colonic motility in the early postoperative period following left colonic anastomosis.西沙必利对左半结肠吻合术后早期远端结肠动力的影响。
Dis Colon Rectum. 1995 Feb;38(2):139-45. doi: 10.1007/BF02052441.
7
Treatment of postoperative paralytic ileus with cisapride.西沙必利治疗术后麻痹性肠梗阻
Scand J Gastroenterol. 1991 May;26(5):477-82. doi: 10.3109/00365529108998569.
8
Cisapride does not reduce postoperative paralytic ileus.西沙必利不能减轻术后麻痹性肠梗阻。
S Afr J Surg. 1987 Mar;25(1):19-21.
9
Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.非溃疡性消化不良患者上腹部疼痛的缓解:促动力药物西沙必利的对照试验
Clin Ther. 1989;11(1):62-8.
10
Effect of intravenous erythromycin on postoperative ileus.
Am J Gastroenterol. 1993 Feb;88(2):208-11.

引用本文的文献

1
Postoperative ileus: impact of pharmacological treatment, laparoscopic surgery and enhanced recovery pathways.术后肠梗阻:药物治疗、腹腔镜手术和加速康复途径的影响。
World J Gastroenterol. 2010 May 7;16(17):2067-74. doi: 10.3748/wjg.v16.i17.2067.
2
Postoperative ileus: progress towards effective management.术后肠梗阻:有效管理的进展
Drugs. 2002;62(18):2603-15. doi: 10.2165/00003495-200262180-00004.
3
Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats.不同促动力药物及一种新型肠动力药物对大鼠术后肠梗阻的影响。
Gut. 1999 Nov;45(5):713-8. doi: 10.1136/gut.45.5.713.
4
A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.西沙必利治疗胃肠道疾病的风险效益评估。
Drug Saf. 1995 Jun;12(6):384-92. doi: 10.2165/00002018-199512060-00004.
5
Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.西沙必利。对其药效学和药代动力学特性以及作为胃肠动力障碍促动力剂的治疗用途的初步综述。
Drugs. 1988 Dec;36(6):652-81. doi: 10.2165/00003495-198836060-00002.
6
Cisapride in intensive care.重症监护中的西沙必利。
Intensive Care Med. 1991;17(8):508-9. doi: 10.1007/BF01690782.